NFKB1 and ovarian cancer: Several natural compounds and synthetic drugs that are able to inhibit the IKK/NF-κB activation pathway have been shown to either prevent cancer or to inhibit cell growth in animal models (Bharti and Aggarwal, 2002), and we suggest further exploration of potential chemotherapeutic properties of NB7M in an ovarian cancer animal model.